Circle Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History

Circle Wealth Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$248K	Hold	1,302	–	–	﹤0.01%	237
2026 Q1	$220K	Buy	+1,302	New	+$223K	﹤0.01%	254
2024 Q3	–	Sell	-3,974	Closed	-$545K	–	218
2024 Q2	$545K	Hold	3,974	–	–	0.01%	156
2024 Q1	$545K	Hold	3,974	–	–	0.01%	138
2023 Q4	$540K	Hold	3,974	–	–	0.01%	133
2023 Q3	$486K	Buy	+3,974	New	+$505K	0.01%	135
2021 Q2	–	Sell	-1,815	Closed	-$273K	–	179
2021 Q1	$273K	Buy	+1,815	New	+$288K	0.04%	147

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Circle Wealth Management's IBB Position: Q2 2026 in Review

Circle Wealth Management held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 1,302 shares worth $248K. The position accounts for ﹤0.01% of the portfolio, ranked #237.

Circle Wealth Management first reported a position in IBB in Q1 2021 and has held it in 7 quarters since. The position peaked at $545K in Q2 2024. 955 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Circle Wealth Management held 1,302 shares of iShares Biotechnology ETF worth $248K as of Q2 2026.
Circle Wealth Management left its iShares Biotechnology ETF share count unchanged in Q2 2026.
iShares Biotechnology ETF made up ﹤0.01% of Circle Wealth Management's portfolio in Q2 2026, its #237 holding.
Circle Wealth Management first reported a position in iShares Biotechnology ETF in Q1 2021 and has held it in 7 quarters since.
Circle Wealth Management's iShares Biotechnology ETF position peaked at $545K in Q2 2024.
955 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Circle Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.